Khanam, Tasneem, Sandmann, Sarah ORCID: 0000-0002-5011-0641, Seggewiss, Jochen, Ruether, Charlotte, Zimmermann, Martin, Norvil, Allison B., Bartenhagen, Christoph, Randau, Gerrit, Mueller, Stephanie, Herbrueggen, Heidi, Hoffmann, Per, Herms, Stefan, Wei, Lanying, Woeste, Marius, Wuensch, Christian, Gowher, Humaira, Oschlies, Ilske, Klapper, Wolfram, Woessmann, Wilhelm, Dugas, Martin and Burkhardt, Birgit ORCID: 0000-0002-1151-829X (2021). Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance. Blood, 137 (17). S. 2347 - 2360. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Full text not available from this repository.

Abstract

T-cell lymphoblastic lymphoma (T-LBL) is a heterogeneous malignancy of lymphoblasts committed to T-cell lineage. The dismal outcomes (15%-30%) after T-LBL relapse warrant establishing risk-based treatment. To our knowledge, this study presents the first comprehensive, systematic, integrated, genome-wide analysis including relapsed cases that identifies molecular markers of prognostic relevance for T-LBL. NOTCH1 was identified as the putative driver for T-LBL. An activated NOTCH/PI3K-AKT signaling axis and alterations in cell cycle regulators constitute the core oncogenic program for T-LBL. Mutated KMT2D was identified as a prognostic marker. The cumulative incidence of relapse was 47% +/- 17% in patients with KMT2D mutations, compared with 14% +/- 3% in wild-type KMT2D. Structural analysis of the mutated domains of KMT2D revealed a plausible impact on structure and functional consequences. These findings provide new insights into the pathogenesis of T-LBL, including high translational potential. The ongoing LBL 2018 trial (www.clinicaltrials.gov #NCT04043494) allows for prospective validation and subsequent fine tuning of the stratification criteria for T-LBL risk groups to improve survival of pediatric patients.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Khanam, TasneemUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sandmann, SarahUNSPECIFIEDorcid.org/0000-0002-5011-0641UNSPECIFIED
Seggewiss, JochenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ruether, CharlotteUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zimmermann, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Norvil, Allison B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bartenhagen, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Randau, GerritUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, StephanieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Herbrueggen, HeidiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoffmann, PerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Herms, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wei, LanyingUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Woeste, MariusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wuensch, ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gowher, HumairaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Oschlies, IlskeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klapper, WolframUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Woessmann, WilhelmUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dugas, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Burkhardt, BirgitUNSPECIFIEDorcid.org/0000-0002-1151-829XUNSPECIFIED
URN: urn:nbn:de:hbz:38-599638
DOI: 10.1182/blood.2020005381
Journal or Publication Title: Blood
Volume: 137
Number: 17
Page Range: S. 2347 - 2360
Date: 2021
Publisher: AMER SOC HEMATOLOGY
Place of Publication: WASHINGTON
ISSN: 1528-0020
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
GENE-EXPRESSION; NOTCH1 MUTATIONS; PROGNOSTIC RELEVANCE; DNA METHYLATION; FBXW7 MUTATIONS; BREAST-CANCER; MLL FAMILY; LEUKEMIA; PTEN; RESISTANCEMultiple languages
HematologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/59963

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item